Cell Therapy Manufacturing

At Genezen, we understand the importance of a streamlined transition from viral vector to cell therapy manufacturing. That’s why we have strong partnerships with world-recognized experts, in order to advance your therapies to clinic with quality and precision.

Scroll Down


With years of clinical experience in cGMP cell therapy manufacturing and deep expertise in lentiviral vectors, we commit substantial industry knowledge to your therapeutic development.

Cell Types

  • CAR T, NK, T lymphocytes and other immune cells
  • Hematopoietic progenitors and stem cells, including MSCs
  • Embryonic and induced pluripotent stem cells (iPSCs)


From bench to clinic, we specialize in early phase production. Alongside our partners, we provide comprehensive and flexible support that molds to your project's needs.

Unique cell services

  • Enrichment or depletion of specific cell subsets
  • Genetic modification (transduction)
  • Expansion and differentiation
  • Cryopreservation
  • Cellular stability studies
  • Suspension cell line development
  • Producer cell lines


Leverage our network of dedicated and experienced partners who can support your development and cGMP manufacturing facilitated and simplified by a Genezen project lead.

Cincinnati Children’s Hospital Medical Center Translational Core Laboratory

  • GMP aseptic cell transduction procedures
  • Certified ISO Class 7 production suites with ISO Class 8 support areas

Cell Therapy Manufacturing insights

Bringing Therapies to Life with Multi-Vector…

Rapid expansion in biotechnology platforms and advancement in genetic editing technologies...

Read more

Understanding the requirements of viral vector…

Analytical method development, qualification, and validation are an integral part of...

Read more

4 factors driving the trend towards…

The cell and gene therapy (C&GT) space is expanding rapidly. With...

Read more

Get insights like this directly to your inbox

Sign up to our newsletter

Looking for something else?